Grady Bryant, MD
Otolaryngology · Hermitage, TNNPI 1134163694
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $54,569 of the $73,611 with a category attached, or 74.1%. Stryker accounts for 91.9% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2019 at $55,869 and has fallen 97.7% since, to $1,298 in 2025. Among otolaryngology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 318 payments — averaging $231.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$68K
- Medical Device Business Services, Inc.$1K
- Regeneron Healthcare Solutions, Inc.$631
- Acclarent, Inc$561
- Sanofi$543
- GSK$519
- plus $3K from 24 others
What the payments were for
- Consulting fees$54,56974%
- Travel & lodging$12,16417%
- Food & beverage$6,8459%
- Education$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 120 | $67,628 |
| Medical Device Business Services, Inc. | 2 | $1,018 |
| Regeneron Healthcare Solutions, Inc. | 22 | $631 |
| Acclarent, Inc | 11 | $561 |
| Sanofi | 22 | $543 |
| GSK | 27 | $519 |
| Aerin Medical Inc. | 6 | $517 |
| Novartis | 25 | $394 |
| Genentech USA, Inc. | 16 | $299 |
| Smith+Nephew | 6 | $260 |
| Integra Lifesciences Corporation | 6 | $203 |
| Kaleo, Inc. | 10 | $168 |
| Optinose US, Inc. | 8 | $165 |
| AstraZeneca | 10 | $145 |
| Intersect ENT, Inc. | 6 | $102 |
| Inspire Medical Systems, Inc. | 3 | $88 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $69 |
| Medtronic | 2 | $44 |
| Alk-abello, Inc | 2 | $39 |
| Amgen | 1 | $34 |
| Neurent Medical Limited | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Gyrus ACMI, Inc. | 1 | $21 |
| Phadia US Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Baxter Healthcare | 1 | $19 |
| Olympus America Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENTELLUS - XPRESS ENT DILATION SYSTEM$65,251
- ENTELLUS - ENTELLUS MEDICAL SHAVER SYSTEM$428
- VIVAER STYLUS$285
- RHINAER STYLUS$285
- XPRESS ENT DILATION SYSTEM$169
- CLARIFIX CRYOTHERAPY DEVICE$162
- TruDi Nav Cable$148
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM$128
- Acclarent Aera$117
- Acclarent Navwire$117
- VivAer$108
- RhinAer$108
How this compares
$73,611 in reported general payments places this provider in the 95th percentile of 191 otolaryngology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $48,057 |
| Ipratropium Bromide | 104 | $3,378 |
| Epinephrine | 16 | $3,229 |
| Azelastine Hcl | 28 | $772 |
| Cefdinir | 26 | $371 |
| Fluticasone Propionate | 27 | $314 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $274 |
| Omeprazole | 38 | $259 |
| Levocetirizine Dihydrochloride | 19 | $257 |
| Famotidine | 23 | $196 |
| Mupirocin | 28 | $184 |
| Methylprednisolone | 22 | $158 |
| Ondansetron OdtOndansetron | 17 | $86 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $58 |
| Promethazine Hcl | 11 | $12 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USAEpinephrine | $14 | $3,22916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 191 otolaryngology providers in Tennessee.
Other otolaryngology in Hermitage
- David FortuneHermitage$298K
- Amit PatelHermitage$11K
- Justin MorganHermitage$6K
- Robert FrankHermitage$4K
- Rakesh ChandraNashville$381K
- Marion GillespieMemphis$67K
- Clyde MathisonFarragut$66K
- Dean KlugGermantown$37K
- Michael TopfNashville$36K
- John GleysteenMemphis$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.